1887

Chapter 11.8 : Immunoassay Detection of Shiga Toxin-Producing

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Immunoassay Detection of Shiga Toxin-Producing , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817435/9781555815271_Chap11_8-1.gif /docserver/preview/fulltext/10.1128/9781555817435/9781555815271_Chap11_8-2.gif

Abstract:

Shiga toxin-producing (STEC) organisms are responsible for a broad range of gastrointestinal illnesses, from mild watery diarrhea to severe hemorrhagic colitis associated with hemolyticuremic syndrome (HUS) ( ). These organisms cause disease primarily through elaboration of one or more Shiga toxins (Stx1, Stx1 variants, Stx2, and Stx2 variants) encoded by genes carried on lambda bacteriophages ( ). Research supports the fact that hemorrhagic colitis and HUS likely result from the action of these toxins on vascular endothelium since Stx targets digalactosyl receptors on microvascular endothelial cells in the gut, kidneys, and brain ( ). organisms that produce Stx2 alone have been found to be more virulent than isolates that have Stx1 alone or that produce Stx1 and Stx2 in combination ( ). Enhanced virulence may also be related to host factors and genetic differences among strains. Some investigators have reported differences in the frequency and distribution of Stx genes in the type of clinical disease reported ( ). Hence, genotyping may be important not only in characterizing particular outbreaks but also in predicting disease severity and treatment ( ). Among other organism virulence factors important for pathogenesis are an adhesin, intimin, encoded by an gene, and enterohemorrhagic (EHEC) hemolysin ( gene), a potent cytolysin ( ).

Citation: Garcia L. 2010. Immunoassay Detection of Shiga Toxin-Producing , p 194-204. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch11.8
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817435.chap11.8
1. Banatvala, N.,, P. M. Griffin,, K. D. Greene,, T. J. Barrett,, W. F. Bibb,, J. H. Green,, J. G. Wells, and the Hemolytic Uremic Syndrome Study Collaborators. 2001. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical and epidemiologic findings. J. Infect. Dis. 183:10631070.
2. Bettelheim, K. A. 2001. Development of a rapid method for the detection of verocytotoxin- producing Escherichia coli (VTEC). Lett. Appl. Microbiol. 32:15.
3. Beutin, L.,, H. Steinruck,, G. Krause,, K. Steege,, S. Haby,, G. Hultsch,, and B. Appel. 2006. Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources. J. Appl. Microbiol. 102:630639.
4. Beutin, L.,, S. Zimmermann,, and K. Gleier. 1996. Rapid detection and isolation of Shiga-like toxin (Verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay. J. Clin. Microbiol. 34:28122814.
5. Brooks, J. T.,, E. G. Sowers,, J. G. Wells,, K. D. Greene,, P. M. Griffin,, R. M. Hoekstra,, and N. A. Strockbine. 2005. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192:14221429.
6. Carroll, K. C.,, K. Adamson,, K. Korgenski,, A. Croft,, R. Hankemeier,, J. Daly,, and C. H. Park. 2003. Comparison of a commercial reversed passive latex agglutination assay to an enzyme immunoassay for the detection of Shiga toxin-producing Escherichia coli. Eur. J. Clin. Microbiol. Infect. Dis. 22:689692.
7.Centers for Disease Control and Prevention. 2006. Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis— New York and North Carolina, 2005. MMWR Morb. Mortal. Wkly. Rep. 29:10421045.
8.Centers for Disease Control and Prevention. 2008. Preliminary FoodNet Data on the incidence of infection with pathogens transmitted commonly through food—10 states, 2007. MMWR Morb. Mortal. Wkly. Rep. 57:366370.
9.Centers for Disease Control and Prevention. 2001. University outbreak of calicivirus infection mistakenly attributed to Shiga toxin-producing Escherichia coli O157:H7—Virginia, 2000. MMWR Morb. Mortal. Wkly. Rep. 50:489491.
10. Chart, H.,, G. A. Willshaw,, and T. Cheasty. 2001. Evaluation of a reversed passive latex agglutination test for the detection of verocytotoxin (VT) expressed by strains of VT-producing Escherichia coli. Lett. Appl. Microbiol. 32:370374.
11.Chart, Council of State and Territorial Epidemiologists. 2001. Position Statements 2000-ID- #1. http://www.cste.org..
12.Denka Seiken Co. Ltd. 2001. VTEC-Screen (II) Seiken product package insert, p. 16. Denka Seiken Co. Ltd., Tokyo, Japan.
13. Fey, P. D.,, R. S. Wickert,, M. E. Rupp,, T. J. Safranek,, and S. H. Hinrichs. 2000. Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg. Infect. Dis. 6:530533.
14. Friedrich, A. W.,, M. Bielaszewska,, W. L. Zhang,, M. Pulz,, T. Kuczius,, A. Ammon,, and H. Karch. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185:7484.
15. Gavin, P. J.,, L. R. Peterson,, A. C. Pasquariello,, J. Blackburn,, M. G. Hamming,, K. J. Kuo,, and R. B. Thomson. 2004. Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli Microplate assay for detection of Shiga toxin-producing E. coli in stool samples. J. Clin. Microbiol. 42:16521656.
16. Grif, K.,, D. Orth,, M. P. Dierich,, and R. Wurzner. 2007. Comparison of an immunochromatographic rapid test with enzyme-linked immunosorbent assay and polymerase chain reaction for the detection of Shiga toxin from human stool samples. Diagn. Microbiol. Infect. Dis. 59:9799.
17.Inverness Medical Professional Diagnostics. 2007. BioStar OIA SHIGATOX package insert. Inverness Medical Professional Diagnostics, Louisville, CO.
18. Jelacic, J. L.,, T. Damrow,, G. S. Chen,, S. Jelacic,, M. Bielaszewska,, M. Ciol,, H. M. Carvalho,, A. R. Melton-Celsa,, A. D. O’Brien,, and P. I. Tarr. 2003. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J. Infect. Dis. 188:719729.
19. Kehl, K. S.,, P. Havens,, C. E. Behnke,, and W. K. Acheson. 1997. Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 35:20512054.
20. Kehl, S. C. 2002. Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections. J. Clin. Microbiol. 40:27112715.
21. Klein, E. J.,, J. R. Stapp,, C. R. Clausen,, D. R. Boster,, J. G. Wells,, X. Qin,, D. L. Swerdlow,, and P. I. Tarr. 2002. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J. Pediatr. 141:172177.
22. Mackenzie, A.,, E. Orrbine,, L. Hyde,, M. Benoit,, F. Chan,, C. Park,, J. Alverson,, A. Lembke,, D. Hoban,, and W. Kennedy. 2000. Performance of the ImmunoCard STAT! E. coli O157:H7 test for detection of Escherichia coli O157:H7 in stools. J. Clin. Microbiol. 38:18661868.
23. Mackenzie, A. M. R.,, P. Lebel,, E. Orrbine,, P. C. Rowe,, L. Hyde,, F. Chan,, W. Johnson,, P. N. McLaine, and The SYNSORB Pk Study Investigators. 1998. Sensitivities and specificities of Premier E. coli O157 and Premier EHEC enzyme immunoassays for diagnosis of infection with verotoxin (Shiga-like toxin)-producing Escherichia coli. J. Clin. Microbiol. 36:16081611.
24. Manning, S. D.,, A. S. Motiwala,, A. C. Springman,, W. Qi,, D. W. Lacher,, L. M. Ouellette,, J. M. Mladonicky,, P. Somsel,, J. T. Rudrik,, S. E. Dietrich,, W. Zhang,, B. Swaminathan,, D. Alland,, and T. S. Whittam. 2008. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. USA 105:48684873.
25.Merck. Duopath verotoxins package insert. Merck, Darmstadt, Germany.
26.Meridian Bioscience, Inc. 2003. Immuno- Card STAT! E. coli O157 Plus, p. 15. Meridian Bioscience, Inc., Cincinnati, OH.
27.Meridian Bioscience, Inc. 2007. Immuno- Card STAT! EHEC. Meridian Bioscience, Inc., Cincinnati, OH..
28.Meridian Bioscience, Inc. 2007. Premier EHEC product package insert, p. 17. Meridian Bioscience, Inc., Cincinnati, OH.
29. Novicki, T. J.,, J. S. Daly,, S. L. Mottice,, and K. C. Carroll. 2000. Comparison of sorbitol MacConkey agar and a two-step method which utilizes a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli. J. Clin. Microbiol. 38:547551.
30. Orth, D.,, K. Grif,, A. B. Khan,, A. Naim,, M. P. Dierich,, and R. Wurzer. 2007. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn. Microbiol. Infect. Dis. 59:235242.
31. Park, C. H.,, H. J. Kim,, D. L. Hixon,, and A. Bubert. 2003. Evaluation of the Duopath verotoxin test for detection of Shiga toxins in cultures of human stools. J. Clin. Microbiol. 41:26502653.
32.R-Biopharm. 2006. RIDASCREEN Verotoxin package insert. R-Biopharm, Darmstadt, Germany.
33.Remel Inc. 2003. ProSpecT Shiga toxin E. coli (STEC) microplate assay package insert. Remel Inc., Lenexa, KS.
34. Serna, A., IV,, and E. D. Boedecker. 2008. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr. Opin. Gastroenterol. 24:3847.
35. Stapp, J. R.,, S. Jelacic,, Y. L. Yea,, E. J. Klein,, M. Fischer,, C. R. Clausen,, X. Qin,, D. L. Swerdlow,, and P. I. Tarr. 2000. Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures. J. Clin. Microbiol. 38:34043406.
36. Tarr, P. I.,, C. A. Gordon,, and W. L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:10731086.
37. Teel, D. L.,, J. A. Daly,, R. C. Jerris,, D. Maul,, G. Svanas,, A. D. O’Brien,, and C. H. Park. 2007. Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay. J. Clin. Microbiol. 45:33773380.
38. Bettelheim, K. A.,, and L. Beutin. 2003. Rapid laboratory identification and characterization of verocytotoxigenic (Shiga toxin producing) Escherichia coli (VTEC/STEC). J. Appl. Microbiol. 95:205217.
39. Ochoa, T. J.,, and T. G. Cleary. 2003. Epidemiology and spectrum of disease of Escherichia coli O157. Curr. Opin. Infect. Dis. 16:259263.

Tables

Generic image for table
Table 11.8-1

Commercial EIA reagents

Citation: Garcia L. 2010. Immunoassay Detection of Shiga Toxin-Producing , p 194-204. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch11.8

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error